Apoptosis-inducing factor

• File:Apoptosis inducing factor.png

Apoptosis-inducing factor

Apoptosis-inducing factor (AIF) is a flavoprotein that plays a crucial role in programmed cell death, also known as apoptosis. AIF is primarily located in the mitochondria and is involved in the regulation of cell death pathways. It is a key player in caspase-independent apoptosis, which is a form of cell death that does not rely on the activation of caspases, the proteases typically associated with apoptotic processes.

Structure and Localization

AIF is encoded by the AIFM1 gene located on the X chromosome. The protein is synthesized as a precursor that is imported into the mitochondria, where it is processed into its mature form. AIF is a flavoprotein, meaning it contains a flavin adenine dinucleotide (FAD) cofactor, which is essential for its function.

In healthy cells, AIF resides in the intermembrane space of the mitochondria. Upon receiving apoptotic signals, AIF translocates from the mitochondria to the cytosol and eventually to the nucleus, where it induces chromatin condensation and large-scale DNA fragmentation.

Function

AIF is involved in both life and death processes within the cell. Under normal conditions, AIF plays a role in oxidative phosphorylation and the maintenance of mitochondrial structure and function. However, in response to apoptotic stimuli, AIF is released from the mitochondria and contributes to cell death.

The release of AIF from the mitochondria is often triggered by mitochondrial outer membrane permeabilization (MOMP), a process that is regulated by members of the Bcl-2 family of proteins. Once in the nucleus, AIF interacts with DNA and other nuclear proteins to promote chromatin condensation and DNA fragmentation, leading to cell death.

Role in Disease

Dysregulation of AIF has been implicated in various diseases. For example, excessive release of AIF can contribute to neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, where inappropriate cell death leads to the loss of neurons. Conversely, reduced AIF activity can impair apoptosis, potentially leading to cancer by allowing damaged cells to survive and proliferate.

Therapeutic Potential

Given its central role in apoptosis, AIF is a potential target for therapeutic intervention. Modulating AIF activity could provide a means to control cell death in diseases where apoptosis is dysregulated. For instance, inhibiting AIF release or function might protect neurons in neurodegenerative diseases, while enhancing AIF activity could promote the death of cancer cells.

Related pages

• Apoptosis
• Mitochondria
• Caspase
• Bcl-2 family
• Neurodegenerative disease